Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immucell (ICCC) Change in Inventory (2016 - 2025)

Historic Change in Inventory for Immucell (ICCC) over the last 16 years, with Q3 2025 value amounting to $1.5 million.

  • Immucell's Change in Inventory rose 83728.1% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 million, marking a year-over-year increase of 303087.89%. This contributed to the annual value of -$699218.0 for FY2024, which is 13943.03% down from last year.
  • Latest data reveals that Immucell reported Change in Inventory of $1.5 million as of Q3 2025, which was up 83728.1% from $937060.0 recorded in Q2 2025.
  • In the past 5 years, Immucell's Change in Inventory ranged from a high of $1.5 million in Q3 2025 and a low of -$662278.0 during Q1 2024
  • Over the past 5 years, Immucell's median Change in Inventory value was $298412.0 (recorded in 2021), while the average stood at $405762.7.
  • In the last 5 years, Immucell's Change in Inventory soared by 2482657.63% in 2021 and then plummeted by 32853.88% in 2024.
  • Immucell's Change in Inventory (Quarter) stood at $423004.0 in 2021, then surged by 70.39% to $720756.0 in 2022, then plummeted by 40.87% to $426178.0 in 2023, then plummeted by 181.62% to -$347829.0 in 2024, then surged by 533.43% to $1.5 million in 2025.
  • Its Change in Inventory stands at $1.5 million for Q3 2025, versus $937060.0 for Q2 2025 and $244743.0 for Q1 2025.